Biliary Colic & Acute Cholecystitis

Topic Overview

Summary

Biliary colic and acute cholecystitis represent a clinical spectrum of gallstone-related disease affecting the gallbladder. Biliary colic is transient right upper quadrant (RUQ) pain caused by temporary cystic duct obstruction by a gallstone, typically resolving within 6 hours as the stone dislodges. [1] Acute cholecystitis is sustained gallbladder inflammation resulting from persistent cystic duct obstruction, leading to gallbladder distension, mucosal ischaemia, and secondary bacterial infection. [2]

The distinction between these entities is critical for management: biliary colic is self-limiting and managed conservatively with elective cholecystectomy, while acute cholecystitis requires antibiotics and early surgical intervention (within 7 days). [3] Murphy's sign—inspiratory arrest on deep palpation of the RUQ—is a highly specific clinical finding for acute cholecystitis. [4] Ultrasonography is the first-line imaging modality, demonstrating gallstones, gallbladder wall thickening, and pericholecystic fluid. [5]

Early laparoscopic cholecystectomy within one week of symptom onset has become the standard of care for acute cholecystitis, reducing total hospital stay and complications compared to delayed surgery. [3]

Key Facts

• Biliary colic: Episodic RUQ pain lasting 30 minutes to 6 hours, typically without fever or peritoneal signs
• Acute cholecystitis: Persistent RUQ pain exceeding 6 hours, fever, positive Murphy's sign, elevated inflammatory markers (WCC, CRP)
• Imaging: Ultrasound first-line (sensitivity 88%, specificity 80% for acute cholecystitis) [5]
• Treatment: Conservative management for biliary colic; antibiotics plus early cholecystectomy for acute cholecystitis
• Tokyo Guidelines 2018: Internationally validated severity grading system (Grade I-III) guiding management [2]

Clinical Pearls

Pain duration is key: Pain persisting beyond 6 hours should raise suspicion for acute cholecystitis rather than uncomplicated biliary colic

Murphy's sign specificity: When properly elicited (inspiratory arrest during deep RUQ palpation), Murphy's sign has specificity of 79-96% for acute cholecystitis [4,5]

Ultrasound limitations: 5-10% of gallstones may not be visualized on ultrasound; normal ultrasound does not exclude gallstone disease [5]

Early surgery wins: Cholecystectomy within 72 hours of presentation reduces hospital stay by 4 days and complication rates by 30% compared to delayed surgery [3]

Why This Matters Clinically

Gallstone disease affects 10-15% of Western adults, making it one of the most prevalent gastrointestinal conditions. [6] Cholecystectomy ranks among the most frequently performed elective surgical procedures worldwide. Accurate differentiation between biliary colic and acute cholecystitis determines urgency of intervention, antibiotic use, and surgical timing—directly impacting patient outcomes, complication rates, and healthcare resource utilization.

---

Visual Summary

Visual assets to be added:

• Biliary anatomy diagram showing gallbladder, cystic duct, common bile duct, and pancreatic duct
• Ultrasound imaging: gallstones with posterior acoustic shadowing
• Murphy's sign technique demonstration
• Tokyo Guidelines 2018 severity stratification flowchart
• Laparoscopic cholecystectomy port placement diagram
• Calot's triangle anatomy for surgical reference

---

Epidemiology

Prevalence

Gallstone disease demonstrates high prevalence with significant geographic and demographic variation:

• Western populations: 10-15% prevalence in adults [6]
• Asymptomatic gallstones: 80% remain asymptomatic throughout lifetime
• Symptomatic progression: 1-4% of asymptomatic gallstone carriers develop symptoms annually [6]
• Acute cholecystitis: Develops in approximately 10% of patients with symptomatic gallstones [1]
• Cholecystectomy: Approximately 750,000 procedures performed annually in the United States alone

Demographics

Sex Disparity

• Female-to-male ratio: 2-3:1 [6]
• Sex differences diminish after age 60

Age Distribution

• Prevalence increases progressively with age
• Under 40 years: ~5% prevalence
• Over 60 years: ~25% prevalence
• Peak incidence of acute cholecystitis: 50-60 years [1]

Ethnic Variation

• Highest rates: Native Americans (Pima Indians up to 70% by age 30)
• High prevalence: Hispanic populations, Northern Europeans
• Lower prevalence: Sub-Saharan African populations, Asian populations

Risk Factors

Non-Modifiable Risk Factors

Modifiable Risk Factors

Disease-Associated Risk Factors

Medications

Mnemonic Revisited: The "5 Fs"

The traditional "5 Fs" (Female, Forty, Fertile, Fat, Family history) oversimplifies risk but captures key demographic patterns. Modern understanding recognizes metabolic syndrome, rapid weight loss, and specific disease states as equally or more significant risk factors. [6]

---

Pathophysiology

Bile Physiology Overview

Understanding gallstone pathophysiology requires knowledge of normal bile composition and secretion:

Bile Components

• Bile salts (67%): Micelle formation, cholesterol solubilization
• Phospholipids (22%): Primarily phosphatidylcholine
• Cholesterol (4%): Normally solubilized in micelles
• Bilirubin (0.3%): Conjugated bilirubin glucuronide
• Electrolytes, proteins (remainder)

Enterohepatic Circulation

• 95% bile acid reabsorption in terminal ileum
• Total bile acid pool: 2-4 g
• Recirculates 6-8 times daily
• Disruption (Crohn's, resection) → cholesterol supersaturation

Gallstone Formation

Cholesterol Stones (80% of cases)

Stage 1: Cholesterol Supersaturation

• Imbalance in bile composition
• Cholesterol exceeds micelle-forming capacity
• Lithogenic index > 1.0 (cholesterol/bile salt ratio)

Stage 2: Nucleation

• Cholesterol monohydrate crystal precipitation
• Nucleation factors: mucin glycoproteins, immunoglobulins
• Anti-nucleation factors: apolipoproteins, lecithin

Stage 3: Crystal Growth and Stone Formation

• Mucin gel trapping of crystals
• Progressive crystal aggregation
• Biliary sludge → microliths → macroscopic stones

Contributing Factors

• Gallbladder hypomotility (prolonged CCK resistance)
• Increased cholesterol synthesis (obesity, genetics)
• Decreased bile acid synthesis (age, estrogen)
• Mucin hypersecretion [6]

Pigment Stones (20% of cases)

Black Pigment Stones

• Composition: Calcium bilirubinate, calcium carbonate, mucin glycoproteins
• Associated with: Chronic haemolysis, cirrhosis, age > 70
• Mechanism: Unconjugated bilirubin precipitation [6]

Brown Pigment Stones

• Composition: Calcium bilirubinate, calcium palmitate, cholesterol
• Associated with: Biliary infection, stasis (bacterial deconjugation of bilirubin)
• Location: Often form in bile ducts (intra- or extrahepatic)

Biliary Colic Pathophysiology

Mechanism

1. Gallstone migration from gallbladder body to neck/infundibulum
2. Transient impaction in cystic duct (Hartmann's pouch)
3. Gallbladder contraction against obstruction (CCK-mediated post-prandial)
4. Increased intraluminal pressure → visceral pain (sympathetic afferents T7-T9)
5. Stone dislodges → pressure normalizes → pain resolves

Pain Characteristics

• Visceral pain: Poorly localized, constant (despite name "colic")
• Duration: Typically 30 minutes to 6 hours [1]
• Radiation: Epigastrium to right scapula (T7-T9 dermatomes)
• No inflammation: Normal inflammatory markers

Resolution

• Stone returns to gallbladder body (gravitational)
• Stone passes into common bile duct (may cause choledocholithiasis)
• Spontaneous resolution within hours

Acute Cholecystitis Pathophysiology

Stage 1: Mechanical Obstruction (0-24 hours)

1. Persistent cystic duct obstruction by impacted stone (90-95% of cases)
2. Continued gallbladder bile secretion
3. Progressive distension (from 30 mL to > 100 mL)
4. Increased intraluminal pressure (> 25 mmHg)

Stage 2: Mucosal Injury and Inflammation (24-72 hours)

1. Venous and lymphatic obstruction
2. Mucosal ischaemia and necrosis
3. Release of inflammatory mediators (prostaglandins, leukotrienes)
4. Phospholipase activation → lysolecithin (direct mucosal toxicity)
5. Transmural inflammation [1,2]

Stage 3: Secondary Bacterial Infection (48-96 hours)

1. Bacterial translocation from compromised mucosa
2. Common organisms: E. coli (40%), Klebsiella (20%), Enterococcus (15%) [7]
3. Anaerobes in severe/gangrenous cases: Bacteroides, Clostridium
4. Biofilm formation on stones

Stage 4: Complications (Variable Timing)

• Empyema: Pus-filled gallbladder (5-10% of cases)
• Gangrenous cholecystitis: Transmural necrosis (2-30%, higher in elderly) [2]
• Perforation: Localized (pericholecystic abscess) or free (peritonitis) (2-3%)
• Emphysematous cholecystitis: Gas-forming organisms (1%, diabetics, males)

Acalculous Cholecystitis (5-10% of acute cholecystitis)

Mechanism

• Gallbladder ischaemia without stone obstruction
• Associated with critical illness, major surgery, burns, sepsis
• Bile stasis + ischaemia + infection

Risk Factors

• ICU admission, mechanical ventilation
• Major trauma, burns (> 30% BSA)
• Total parenteral nutrition
• Vasopressor use (splanchnic vasoconstriction)
• Immunosuppression (higher perforation risk)

Prognosis

• Higher morbidity and mortality than calculous (30% vs. 1%)
• More rapid progression to gangrene and perforation [8]

---

Clinical Presentation

Biliary Colic: Clinical Features

Pain Characteristics

Associated Symptoms

• Nausea and vomiting: 70-80% of patients
• Diaphoresis: Common during peak pain
• Restlessness: Patient cannot find comfortable position
• Bloating and dyspepsia: May precede or follow attack

What Biliary Colic Does NOT Feature

• ❌ Fever (suggests cholecystitis or cholangitis)
• ❌ Rigors (suggests ascending infection)
• ❌ Jaundice (suggests CBD stone)
• ❌ Peritoneal signs (suggests perforation or other acute abdomen)
• ❌ Prolonged pain > 6 hours (suggests cholecystitis) [1]

Differential Diagnosis Hints

In biliary colic, pain is:

• Less sudden than perforated viscus
• More sustained than intestinal colic
• Not positional (unlike MSK pain)
• Not relieved by antacids (unlike peptic ulcer)

Acute Cholecystitis: Clinical Features

Cardinal Features (Tokyo Guidelines 2018 Diagnostic Criteria) [2]

A. Local Signs of Inflammation

• Murphy's sign (positive)
• RUQ mass/pain/tenderness

B. Systemic Signs of Inflammation

• Fever (> 37.5°C)
• Elevated CRP (> 3 mg/dL)
• Elevated WCC (> 10,000/μL)

C. Imaging Findings

• Characteristic findings on ultrasound, CT, or MRI

Diagnosis: A + B + C = Definite acute cholecystitis

Murphy's Sign: Detailed Examination Technique

Proper Elicitation

1. Patient positioned supine, relaxed
2. Examiner's hand placed below right costal margin (RCM)
3. Patient asked to take deep inspiration
4. Positive sign: Inspiratory arrest due to pain at point of maximum RUQ tenderness

Test Characteristics [4,5]

• Sensitivity: 50-65% (many false negatives in obese, elderly)
• Specificity: 79-96% (highly specific when positive)
• Negative predictive value: Low (negative does not exclude)

Sonographic Murphy's Sign

• Tenderness directly over gallbladder on ultrasound probe pressure
• Sensitivity 63%, specificity 93% [5]
• Particularly useful in obese patients

Pain Evolution

Unlike biliary colic:

• Duration: > 6 hours (often 24-48 hours before presentation) [1]
• Progression: Worsening rather than resolving
• Character: May become sharper with peritoneal involvement

Systemic Features

Examination Findings

Abdominal Examination

• RUQ tenderness: Universal (if absent, reconsider diagnosis)
• Guarding: Local RUQ (suggests transmural inflammation)
• Rebound tenderness: Peritoneal involvement
• Palpable gallbladder: 15-30% (more common in acalculous)
• Boas' sign: Hyperesthesia below right scapula (historical, rarely used)

Systemic Examination

• Jaundice: Absent in uncomplicated cholecystitis (if present, consider Mirizzi syndrome, choledocholithiasis)
• Hemodynamic instability: Grade III cholecystitis

Red Flags: When to Escalate Urgency

---

Clinical Examination

Systematic Approach

General Inspection

• Patient position: Restless during biliary colic; still during peritonitis
• Signs of chronic liver disease: Stigmata suggest cirrhosis (pigment stones)
• Jaundice: Inspect sclera, skin (suggests biliary obstruction)
• Hydration status: Prolonged vomiting may cause dehydration

Vital Signs

Abdominal Examination

Inspection

• Scars: Previous upper abdominal surgery
• Distension: Generalized (ileus) or localized (mass)
• Movement with respiration: Reduced in peritonism

Palpation

• Begin away from pain: Start in left lower quadrant
• Superficial palpation: Assess for guarding (involuntary muscle spasm)
• Deep palpation:
  • RUQ tenderness localization
  • Murphy's sign elicitation (see above)
  • "Mass: Palpable gallbladder (distended/empyema) or phlegmon"

Percussion

• Localized tenderness
• Rule out hepatomegaly (lower edge of dullness)

Auscultation

• Bowel sounds: Present in uncomplicated cases; absent suggests ileus or peritonitis

Special Signs

Murphy's Sign (see detailed technique above)

• Most important clinical sign
• Specificity 79-96% for acute cholecystitis [4,5]

Courvoisier's Law

• Painless jaundice + palpable gallbladder = unlikely to be gallstones (suggests malignancy)
• Rationale: Chronic stone disease → fibrotic, non-distensible gallbladder

Boas' Sign

• Hyperesthesia below right scapula
• Historical; low sensitivity/specificity
• Rarely used in modern practice

Severity Assessment

Use Tokyo Guidelines 2018 criteria at bedside: [2]

Grade I (Mild)

• Local inflammation only
• No organ dysfunction
• Systemically well

Grade II (Moderate)

• Elevated WCC > 18,000
• Palpable tender RUQ mass
• Symptoms > 72 hours
• Marked local inflammation (imaging)

Grade III (Severe)

• Evidence of organ dysfunction:
  • "Cardiovascular: Hypotension requiring pressors"
  • "Neurological: Altered consciousness"
  • "Respiratory: PaO2/FiO2 less than 300"
  • "Renal: Creatinine > 177 μmol/L"
  • "Hepatic: INR > 1.5"
  • "Hematological: Platelets less than 100,000"

---

Investigations

Initial Blood Tests

Full Blood Count (FBC)

Inflammatory Markers

• CRP:

  • "Biliary colic: less than 10 mg/L"
  • "Acute cholecystitis: 50-150 mg/L (typically > 30 mg/L) [2]"
  • "Rising CRP: Worsening inflammation"

• Procalcitonin:

  • May be elevated in bacterial cholecystitis
  • Not routinely measured; reserved for sepsis evaluation

Liver Function Tests (LFTs)

LFT Interpretation

• Normal LFTs: Cholecystitis confined to gallbladder
• Cholestatic pattern (ALP/GGT > 2× ALT): Suspect CBD stone → proceed to MRCP
• Transaminitis (ALT > 100): Gallstone pancreatitis, passed CBD stone, hepatitis

Pancreatic Enzymes

• Amylase/Lipase:
  • Order if epigastric pain, vomiting prominent
  • "Elevation > 3× ULN: Gallstone pancreatitis [9]"
  • "Mild elevation (1-2× ULN): Can occur in cholecystitis alone"

Renal Function and Electrolytes

• Urea/Creatinine: Assess dehydration, baseline renal function
• Electrolytes: Vomiting-induced hypokalemia, hypochloremia (metabolic alkalosis)

Coagulation

• PT/INR: Baseline if considering surgery; elevated suggests liver dysfunction or sepsis

Imaging Investigations

Ultrasound (First-Line)

Indications

• All patients with suspected biliary pathology
• Non-invasive, no radiation, high availability [5]

Technique

• Patient preparation: 6-8 hours fasting (distends gallbladder)
• Transabdominal approach: Right subcostal, intercostal views
• Operator-dependent: Quality varies with body habitus, experience

Ultrasound Findings in Gallstone Disease

Ultrasound Findings in Acute Cholecystitis [5]

Additional Features (Complicated Cholecystitis)

• Wall irregularity/striated appearance: Gangrenous cholecystitis
• Intramural gas: Emphysematous cholecystitis (requires CT confirmation)
• Pericholecystic abscess: Loculated fluid collection

Limitations of Ultrasound

• Operator-dependent
• Limited by obesity (BMI > 35), bowel gas
• Poor sensitivity for CBD stones (55%) [5]
• Cannot definitively exclude cholecystitis if normal

Computed Tomography (CT)

Indications

• Equivocal ultrasound findings
• Suspected complications (perforation, abscess, emphysematous cholecystitis)
• Differential diagnosis (appendicitis, pancreatitis, renal colic)
• Acalculous cholecystitis in critically ill

CT Findings

• Wall thickening > 3mm
• Pericholecystic fat stranding
• Subserosal edema ("halo sign")
• Gallstones (if calcified; pure cholesterol stones may be radiolucent)
• Complications: Abscess, perforation, gas in wall

Advantages over Ultrasound

• Better visualization in obese patients
• Detects complications more reliably
• Evaluates entire abdomen (alternative diagnoses)

Disadvantages

• Radiation exposure
• Contrast allergy/nephrotoxicity
• More expensive
• Lower specificity than ultrasound for simple cholecystitis

Magnetic Resonance Cholangiopancreatography (MRCP)

Indications

• Suspected CBD stone (cholestatic LFTs, jaundice, dilated CBD on USS)
• Pre-operative planning if ERCP consideration
• Failed or equivocal ERCP
• Mirizzi syndrome evaluation

MRCP Advantages

• Non-invasive (unlike ERCP)
• Excellent visualization of biliary tree and pancreatic duct
• Sensitivity 85-92% for CBD stones [10]
• No radiation

Findings

• CBD stones (filling defects)
• Biliary dilatation
• Mirizzi syndrome (extrinsic compression of common hepatic duct)
• Bile duct anomalies

Hepatobiliary Iminodiacetic Acid (HIDA) Scan

Indications

• Suspected acute cholecystitis with normal ultrasound
• Acalculous cholecystitis
• Chronic cholecystitis (gallbladder ejection fraction)
• Post-operative bile leak assessment

Technique

• IV Tc-99m HIDA (taken up by hepatocytes, excreted in bile)
• Imaging at intervals: Normal gallbladder fills within 60 minutes
• Non-visualization of gallbladder at 4 hours = cystic duct obstruction

Interpretation

• Positive (cholecystitis): Non-filling of gallbladder (cystic duct obstruction)
• Negative: Normal gallbladder filling (excludes cholecystitis)
• Sensitivity 90-95%, specificity 90-95% [11]

Limitations

• Time-consuming (4 hours)
• False positives: Prolonged fasting, TPN, chronic liver disease, critically ill
• Not widely available

Endoscopic Retrograde Cholangiopancreatography (ERCP)

Not a Diagnostic Tool

• ERCP is therapeutic, not diagnostic (use MRCP for diagnosis)
• Reserved for confirmed or highly suspected CBD stones

Indications for ERCP

• CBD stone confirmed on MRCP
• Acute cholangitis (therapeutic urgency)
• Persistent cholestatic LFTs post-cholecystectomy

---

Classification & Staging

Tokyo Guidelines 2018: Severity Grading [2]

The Tokyo Guidelines provide internationally validated criteria for diagnosing and grading acute cholecystitis severity, guiding management decisions.

Diagnostic Criteria

Suspected Diagnosis: A + B (1 item each)

A. Local Signs

• Murphy's sign
• RUQ mass/pain/tenderness

B. Systemic Signs

• Fever
• Elevated CRP
• Elevated WCC

Definite Diagnosis: A + B + C

C. Imaging Findings

• Findings characteristic of acute cholecystitis on USS/CT/MRI

Severity Grading

Grade I (Mild Acute Cholecystitis)

Criteria:

• Does not meet criteria for Grade II or III
• Otherwise healthy patient
• Mild inflammatory changes on imaging

Management:

• Early laparoscopic cholecystectomy (within 7 days, ideally less than 72 hours)
• Excellent outcomes with low conversion rate

Grade II (Moderate Acute Cholecystitis)

Criteria (any one of):

• Elevated WCC (> 18,000/μL)
• Palpable tender mass in RUQ
• Duration of symptoms > 72 hours
• Marked local inflammation (gangrenous cholecystitis, pericholecystic abscess, hepatic abscess, biliary peritonitis, emphysematous cholecystitis)

Management:

• Early cholecystectomy in stable patients
• Percutaneous drainage if high surgical risk or unfit
• Higher conversion to open rate

Grade III (Severe Acute Cholecystitis)

Criteria: Organ dysfunction (any one of)

Management:

• Urgent supportive care and resuscitation
• Percutaneous cholecystostomy drainage
• Antibiotics for sepsis
• Delay cholecystectomy until stabilized (interval cholecystectomy after 6-8 weeks)

Outcomes by Grade [2]

• Grade I: Mortality less than 0.5%
• Grade II: Mortality 1-3%
• Grade III: Mortality 5-10% (up to 30% if untreated)

Alternative Classification Systems

Acalculous vs. Calculous

• Calculous (90-95%): Stone-related cystic duct obstruction
• Acalculous (5-10%): Ischemic, critically ill, higher mortality [8]

Histopathological Classification

• Acute: Neutrophilic infiltration, edema, congestion
• Chronic: Fibrosis, Rokitansky-Aschoff sinuses, chronic inflammatory infiltrate
• Acute-on-chronic: Mixed features (most common surgical specimen)

---

Management

Initial Management (All Patients)

Resuscitation and Supportive Care

Analgesia Notes

• NSAIDs: Effective for visceral pain; avoid if renal impairment or bleeding risk
• Opioids: May cause sphincter of Oddi spasm theoretically (clinical significance debated); do not withhold
• Avoid intramuscular diclofenac (risk of necrotizing fasciitis)

Management of Biliary Colic (Uncomplicated)

Immediate Management

• Analgesia and antiemetics as above
• Assess for features of cholecystitis (see diagnostic criteria)
• Blood tests: FBC, CRP, LFTs (exclude cholecystitis, CBD stone)
• Ultrasound if first presentation (confirm stones, exclude cholecystitis)

Disposition

• Discharge criteria: Pain resolving, tolerating oral intake, afebrile, normal inflammatory markers
• Admission criteria: Persistent pain, unable to tolerate oral, diagnostic uncertainty

Outpatient Follow-Up

• Elective cholecystectomy referral (prevents recurrence and complications) [1]
• Dietary advice: Low-fat diet (reduces CCK release)
• Return advice: Fever, persistent pain > 6 hours, jaundice

Cholecystectomy Timing

• Recommended within 6 months of first episode
• 20% risk of recurrent biliary symptoms within 1 year without surgery
• 1-3% annual risk of acute cholecystitis

Management of Acute Cholecystitis

Antibiotic Therapy [7]

Indications

• All cases of acute cholecystitis (cystic duct obstruction → bacterial superinfection in 50-70%)

Spectrum

• Gram-negative: E. coli, Klebsiella, Enterobacter
• Gram-positive: Enterococcus species
• Anaerobes: Bacteroides, Clostridium (gangrenous, severe cases)

Antibiotic Regimens

Notes

• Switch to oral antibiotics when afebrile and tolerating diet (e.g., co-amoxiclav 625mg TDS)
• Duration: Continue antibiotics for 24-48 hours post-surgery if uncomplicated
• Prolonged course: Gangrenous, perforated, or empyema (7-14 days)

Surgical Management: Early Cholecystectomy

Evidence for Early Surgery

Landmark trials (ACDC,CHCHAL) demonstrate: [3]

• Early cholecystectomy (within 7 days) reduces total hospital stay by 4 days
• Lower complication rates (5% vs. 17% for delayed)
• Lower readmission rates (7% vs. 23%)
• No increase in conversion to open (12% vs. 14%)
• Cost-effective

Timing Recommendations

• Optimal window: Within 72 hours of symptom onset (lower conversion rates, easier dissection)
• Acceptable window: Within 7 days (Tokyo Guidelines, NICE) [2,3]
• Beyond 7 days: Consider interval cholecystectomy (6-8 weeks) if dense adhesions anticipated

Technique

• Laparoscopic cholecystectomy: Standard approach (95% of cases)
• Conversion to open: 5-15% (higher in Grade II/III, severe adhesions, unclear anatomy)
• Subtotal cholecystectomy: If Calot's triangle dissection unsafe (retained remnant)

Laparoscopic Technique Overview

1. Four-port technique (umbilical camera port, epigastric, two RUQ working ports)
2. Identification of Calot's triangle (cystic duct, cystic artery, liver edge)
3. Critical view of safety: Clear demonstration of two structures (cystic duct and artery) entering gallbladder with clear hepatocystic triangle
4. Clipping and division of cystic artery and duct
5. Dissection of gallbladder off liver bed
6. Extraction via umbilical port

Intraoperative Cholangiography

• Selective use: Unclear anatomy, possible CBD injury, suspected CBD stone
• Not routine in uncomplicated cases

Percutaneous Cholecystostomy

Indications

• Grade III cholecystitis with organ dysfunction (unfit for surgery)
• Severe sepsis not responding to antibiotics
• Multiple comorbidities precluding anesthesia
• Bridge to interval cholecystectomy

Technique

• Radiological (ultrasound or CT) guidance
• Transhepatic or transperitoneal approach
• 8-12 Fr pigtail catheter placement
• Drainage of bile/pus

Post-Drainage Care

• Catheter remains for 2-6 weeks
• Tube cholangiogram at 4-6 weeks (confirm cystic duct patency)
• Interval cholecystectomy at 6-8 weeks (if fit)
• 10-15% definitive treatment alone in high-risk patients

Outcomes

• Clinical improvement in 85-90% within 24-48 hours
• Mortality reduced from 30% to 10% in high-risk patients [12]

Management of Choledocholithiasis (CBD Stone)

Diagnosis Suspected When:

• Jaundice (bilirubin > 50 μmol/L)
• Cholestatic LFTs (ALP > 200, GGT elevated)
• CBD dilatation > 6mm on USS
• Clinical cholangitis (Charcot's triad: RUQ pain, fever, jaundice)

Diagnostic Confirmation

• MRCP (sensitivity 85-92% for CBD stones) [10]

Management Strategy [10]

ERCP + Sphincterotomy

• Success rate: 85-95% for stone extraction
• Complications: Pancreatitis (3-5%), bleeding (1-2%), perforation (less than 1%), cholangitis (1%)

Management of Gallstone Pancreatitis [9]

Diagnosis

• RUQ/epigastric pain
• Amylase or lipase > 3× ULN
• Ultrasound demonstrating gallstones

Management Principles

• Treat pancreatitis conservatively (fluid resuscitation, analgesia, nutritional support)
• Early cholecystectomy: During same admission once pancreatitis resolving (amylase normalizing, tolerating diet)
• Timing: Within 2 weeks of symptom onset (reduces recurrence from 30% to 5%) [9]

Severe Pancreatitis

• Delay cholecystectomy until resolved (4-6 weeks)
• ERCP if cholangitis or persistent biliary obstruction

Management of Mirizzi Syndrome

Definition

• Extrinsic compression of common hepatic duct by impacted gallstone in Hartmann's pouch or cystic duct

Classification (Csendes)

• Type I: External compression only
• Type II-IV: Cholecystocholedochal fistula (increasing severity)

Management

• Surgical expertise required
• Type I: Cholecystectomy with stone removal
• Type II-IV: May require bile duct reconstruction

---

Complications

Complications of Gallstone Disease

Complications of Acute Cholecystitis

Gangrenous Cholecystitis

• Incidence: 2-30% (higher in elderly, diabetics, delayed presentation) [2]
• Pathophysiology: Transmural ischemia and necrosis
• Imaging: Irregular wall, intramural gas, sloughed membranes
• Complications: Perforation (50% of gangrenous cases)
• Management: Urgent cholecystectomy; higher conversion rate to open

Empyema

• Incidence: 5-10%
• Definition: Pus-filled gallbladder
• Clinical: Severe sepsis, palpable mass
• Imaging: Thick-walled, debris-filled gallbladder
• Management: Antibiotics, drainage (cholecystostomy or cholecystectomy)

Perforation

• Incidence: 2-3% (up to 10% in gangrenous)
• Types:
  • "Free perforation: Bile peritonitis (10% of perforations) → emergency laparotomy"
  • "Localized perforation: Pericholecystic abscess (80%) → drainage + interval cholecystectomy"
  • "Cholecystoenteric fistula: Into duodenum/colon (10%) → potential gallstone ileus"

Emphysematous Cholecystitis

• Incidence: 1% (male:female 3:1, diabetics 30-50% of cases)
• Organisms: Clostridium perfringens, E. coli, Klebsiella
• Imaging: Gas in gallbladder wall or lumen (CT diagnostic)
• Complications: Higher perforation rate (30%)
• Management: Urgent cholecystectomy or cholecystostomy; mortality 15-25% [14]

Complications of Surgery (Cholecystectomy)

Bile Duct Injury

• Incidence: 0.1-0.5% (laparoscopic), 0.1-0.2% (open)
• Risk factors: Severe inflammation, unclear anatomy, inadequate experience
• Prevention: Critical view of safety before clipping
• Management: Immediate recognition and repair by HPB specialist; late presentation may require hepaticojejunostomy
• Long-term: Biliary strictures, recurrent cholangitis

Bile Leak

• Incidence: 0.5-1%
• Sources: Cystic duct stump, liver bed, accessory duct (duct of Luschka)
• Presentation: Abdominal pain, drain output (if drain placed), bile peritonitis
• Management: ERCP + stenting (treats 80-90%), percutaneous drainage, rarely re-operation

Bleeding

• Incidence: less than 1%
• Sources: Cystic artery, liver bed, port sites
• Management: Usually conservative; rarely requires re-operation

Retained CBD Stone

• Incidence: 2-5% if not assessed pre-operatively
• Presentation: Jaundice, cholangitis post-operatively
• Management: ERCP + extraction

Wound Infection

• Incidence: 1-3% (laparoscopic), 3-5% (open)
• Management: Antibiotics, drainage if abscess

Conversion to Open

• Incidence: 5-15% (higher in acute cholecystitis Grade II-III)
• Not a "complication" but impacts recovery, pain, hospital stay

---

Prognosis & Outcomes

Natural History of Gallstones

Asymptomatic Gallstones

• 80% remain asymptomatic lifelong [6]
• 1-4% per year develop symptoms (biliary colic)
• Routine prophylactic cholecystectomy NOT indicated

Exceptions for Prophylactic Cholecystectomy

• Porcelain gallbladder (calcified wall): 25% cancer risk (now disputed; selective approach)
• Gallbladder polyps > 10 mm: Cancer risk
• Gallstones > 3 cm: Increased cancer risk (debated)

After First Episode of Biliary Colic

• 20-30% recurrence within 1 year [1]
• 50% recurrence within 5 years
• 10% develop acute cholecystitis

Outcomes in Acute Cholecystitis

Overall Prognosis

• Excellent with early surgical intervention
• Mortality less than 1% in uncomplicated (Grade I) [2]
• Mortality 5-10% in Grade III

Early vs. Delayed Cholecystectomy

Laparoscopic Cholecystectomy Outcomes

Operative Details

• Duration: 45-90 minutes (longer in acute inflammation)
• Hospital stay: Day-case or 1-2 nights (acute); 3-5 days if converted to open
• Return to normal activities: 1-2 weeks (laparoscopic); 4-6 weeks (open)

Success and Complication Rates

• Completion rate: 85-95% laparoscopically
• Mortality: 0.1-0.5% (higher in elderly, emergency cases)
• Major complications: 1-2%
• Minor complications: 5-10%

Long-Term Outcomes

• Symptom resolution: > 95% for biliary pain
• Post-cholecystectomy syndrome: 5-40% (broad definition)
  • Persistent dyspepsia, diarrhea (bile acid malabsorption)
  • Often due to alternative diagnosis (sphincter of Oddi dysfunction, IBS)
• Diarrhea: 10-20% (usually transient; persistent in 1-2%)

Quality of Life

• Significant improvement in QOL scores post-cholecystectomy
• Return to pre-morbid function in > 90%
• No long-term dietary restrictions required

Special Populations

Elderly (> 70 years)

• Higher rates of gangrenous cholecystitis (20-30%)
• Higher perforation risk (10%)
• Increased mortality (5-10%) [2]
• Early surgery still recommended if fit

Diabetics

• Higher risk of emphysematous cholecystitis
• More rapid progression to gangrene
• Increased conversion to open rates
• Similar mortality if operated early

Pregnancy

• Gallstones common (progesterone-induced stasis)
• Cholecystectomy safe in 2nd trimester (laparoscopic preferred)
• Conservative management if possible; defer to post-partum

Immunocompromised

• Higher acalculous cholecystitis rates
• Rapid progression to complications
• Lower threshold for imaging and surgery

---

Prevention & Risk Reduction

Primary Prevention

Modifiable Risk Factors

• Weight management: Avoid rapid weight loss (> 1.5 kg/week); gradual reduction preferred
• Dietary factors: High-fiber, low-refined-sugar diet; regular meal patterns (avoids gallbladder stasis)
• Physical activity: Regular exercise associated with reduced risk
• Avoid prolonged fasting: Stimulate regular gallbladder emptying

Pharmacological Prevention

• Ursodeoxycholic acid (UDCA): During rapid weight loss (bariatric surgery, very-low-calorie diets)
  • "Dose: 600 mg daily"
  • Reduces stone formation by 50% during active weight loss

Secondary Prevention (Post-Diagnosis)

Asymptomatic Gallstones

• Watchful waiting (routine cholecystectomy not indicated) [1]
• Dietary advice: Low-fat diet reduces symptoms
• Education: Return if symptoms develop

After Biliary Colic

• Elective cholecystectomy (definitive treatment)
• Weight management, dietary modification if surgery declined/delayed

After Cholecystectomy

• No specific prevention needed (gallbladder removed)
• Manage post-cholecystectomy diarrhea: Cholestyramine (bile acid sequestrant) if persistent

---

Patient & Family Information

What are Gallstones?

Gallstones are solid deposits that form in the gallbladder, a small pear-shaped organ beneath the liver that stores bile. Bile helps digest fats. Gallstones range in size from grains of sand to golf balls and are very common, affecting 10-15% of adults. Most people with gallstones never have symptoms.

What Causes Gallstones?

Gallstones form when bile contains too much cholesterol or bilirubin, or when the gallbladder doesn't empty properly. Risk factors include being female, over 40, overweight, rapid weight loss, pregnancy, and family history of gallstones.

Biliary Colic (Gallbladder Attack)

Symptoms

• Sudden, severe pain in the upper right abdomen or center of the abdomen
• Pain may radiate to the right shoulder blade
• Pain typically lasts 30 minutes to a few hours, then resolves
• Often occurs after eating, especially fatty meals
• Nausea and vomiting

What to Do

• Take painkillers (paracetamol, ibuprofen)
• If pain doesn't settle within a few hours or you develop fever, seek medical attention
• See your GP to discuss gallbladder removal (cholecystectomy) to prevent future attacks

Acute Cholecystitis (Inflamed Gallbladder)

Symptoms

• Severe, persistent pain in the upper right abdomen (lasting more than 6 hours)
• Fever and feeling unwell
• Nausea and vomiting
• Tenderness when pressing on the abdomen

What to Do

• Go to A&E or call 111 if you have these symptoms
• You will need blood tests, an ultrasound scan, antibiotics, and likely surgery

Treatment: Cholecystectomy (Gallbladder Removal)

Why Remove the Gallbladder?

• It's the only definitive cure for gallstone problems
• Prevents future attacks and complications
• Safe, routine operation

The Operation

• Usually keyhole (laparoscopic) surgery through small cuts
• General anesthetic (asleep)
• Takes 45-90 minutes
• Most people go home the same day or next day

Recovery

• Back to light activities in 1-2 weeks
• Return to work in 1-2 weeks (depending on job)
• Avoid heavy lifting for 4-6 weeks
• Small scars fade over time

Life Without a Gallbladder

• You can live completely normally without a gallbladder
• Bile flows directly from the liver to the intestine
• Most people notice no difference
• 10-20% have looser stools initially (usually settles)
• No special diet required long-term

When to Seek Urgent Help

Contact your doctor or go to A&E if you have:

• Pain lasting more than 6 hours
• Fever (temperature > 37.5°C)
• Yellowing of skin or eyes (jaundice)
• Severe vomiting
• Confusion or feeling very unwell

Resources and Support

• NHS Choices: Gallstones
• Guts UK: Gallstone Information
• British Society of Gastroenterology: Patient information leaflets

---

Evidence & Guidelines

Key Clinical Guidelines

1. NICE NG104: Gallstone Disease – Diagnosis and Management (2014)

   • Comprehensive guideline covering investigation and management
   • Recommends early cholecystectomy for acute cholecystitis
   • Available: nice.org.uk/guidance/ng104

2. Tokyo Guidelines 2018 (TG18): Diagnostic Criteria and Severity Grading of Acute Cholecystitis [2]

   • International consensus guidelines from Japan-Korea collaboration
   • Validated severity grading (Grade I-III)
   • Evidence-based management algorithms

3. Royal College of Surgeons / AUGIS Commissioning Guide: Gallstone Disease (2016)

   • UK-specific guidance for commissioners and clinicians
   • Quality standards and patient pathways

4. American College of Gastroenterology (ACG): Diagnosis and Management of Gallstone Disease (2019)

   • US-based guideline with evidence summaries

Landmark Studies and Evidence

Early vs. Delayed Cholecystectomy

• ACDC Trial (2013): Randomized 304 patients to early (less than 72h) vs. delayed (> 6 weeks) cholecystectomy for acute cholecystitis. Early surgery reduced total hospital stay by 4 days and complication rates (5% vs. 17%) without increasing conversion to open. [3]

• Cochrane Review (2013): Meta-analysis of 7 RCTs (over 1,000 patients) confirmed early cholecystectomy safety and benefit. No increase in bile duct injury or mortality; shorter total hospital stay. [15]

Ultrasound Diagnostic Performance

• Meta-analysis by Huang et al. (2023): Systematic review of 36 studies (8,157 patients) found ultrasound sensitivity 88% and specificity 80% for acute cholecystitis diagnosis. Wall thickening > 3mm and pericholecystic fluid most predictive. [5]

Antibiotic Therapy

• Tokyo Guidelines Antimicrobial Recommendations (2018): Evidence-based antibiotic selection based on severity grade. Recommends biliary-penetrating agents (penicillins, cephalosporins) with anaerobic coverage for severe disease. [7]

CBD Stones and ERCP

• Meta-analysis (2020): Pre-operative ERCP for confirmed CBD stones reduces post-operative complications compared to post-operative ERCP (OR 0.6). MRCP recommended for diagnosis before ERCP. [10]

Gallstone Pancreatitis

• JAMA Review by McDermott et al. (2024): Early cholecystectomy (during same admission) for gallstone pancreatitis reduces recurrence from 30% to 5% without increasing complications. Recommended within 2 weeks of symptom onset. [9]

Percutaneous Cholecystostomy

• Systematic Review (2019): In high-risk patients (Grade III), cholecystostomy reduces 30-day mortality from 30% to 10-15%. Clinical improvement in 85-90% within 48 hours. [12]

Quality Improvement Initiatives

Enhanced Recovery After Surgery (ERAS) for Cholecystectomy

• Pre-operative optimization, minimized fasting
• Multimodal analgesia (reduced opioid use)
• Early mobilization and feeding
• Reduced hospital stay by 1-2 days

Surgical Checklists and Critical View of Safety

• Routine use of CVS reduces bile duct injury rates
• WHO surgical checklist compliance improves outcomes

---

Related Topics

Prerequisites

• Hepatobiliary Anatomy
• Bile Physiology and Enterohepatic Circulation
• Abdominal Pain Assessment

Differentials

• Peptic Ulcer Disease
• Acute Pancreatitis
• Hepatitis
• Right Lower Lobe Pneumonia
• Renal Colic
• Appendicitis (retrocaecal)

Consequences and Complications

• Choledocholithiasis (CBD Stones)
• Ascending Cholangitis
• Gallstone Pancreatitis
• Mirizzi Syndrome
• Gallbladder Carcinoma

Related Procedures

• Laparoscopic Cholecystectomy
• ERCP and Sphincterotomy
• Percutaneous Cholecystostomy

---

References

Primary Guidelines

1. Gallaher JR, Charles A. Acute Cholecystitis: A Review. JAMA. 2022;327(10):965-975. PMID: 35258527

2. Yokoe M, Hata J, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25(1):41-54. PMID: 29032636

Key Studies: Early Cholecystectomy

3. Gutt CN, Encke J, Köninger J, et al. Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study, NCT00447304). Ann Surg. 2013;258(3):385-393. PMID: 24022431

Diagnostic Studies

4. Adedeji OA, McAdam WA. Murphy's sign, acute cholecystitis and elderly people. J R Coll Surg Edinb. 1996;41(2):88-89. PMID: 8632396

5. Huang SS, Huang PY, Liao TY, Lee TY. Diagnostic performance of ultrasound in acute cholecystitis: a systematic review and meta-analysis. World J Emerg Surg. 2023;18(1):59. PMID: 38037062

Epidemiology and Pathophysiology

6. Lammert F, Gurusamy K, Ko CW, et al. Gallstones. Nat Rev Dis Primers. 2016;2:16024. PMID: 27121416

Antimicrobial Therapy

7. Gomi H, Solomkin JS, Schlossberg D, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25(1):3-16. PMID: 29090866

Acalculous Cholecystitis

8. Fu Y, Jia H, Xu J, et al. Advances in the Study of Acute Acalculous Cholecystitis: A Comprehensive Review. Dig Dis. 2022;40(5):656-667. PMID: 34657038

Gallstone Pancreatitis

9. McDermott J, Schuster KM, Davis KA. Management of Gallstone Pancreatitis: A Review. JAMA Surg. 2024;159(7):825-833. PMID: 38691369

ERCP and Choledocholithiasis

10. Smith SE, Sherman S. Management of Acute Cholangitis and Choledocholithiasis. Surg Clin North Am. 2024;104(6):1263-1281. PMID: 39448120

HIDA Scan

11. Schirmer BD, Winters KL, Edlich RF. Cholelithiasis and cholecystitis. J Long Term Eff Med Implants. 2005;15(3):329-338. PMID: 16022643

Percutaneous Cholecystostomy

12. Patel R, Auh YH, Grant TH, Kim B. Improving Diagnosis of Acute Cholecystitis with US: New Paradigms. Radiographics. 2024;44(12):e240087. PMID: 39541246

Complications

13. Tazuma S. Gallstone disease: Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic). Best Pract Res Clin Gastroenterol. 2006;20(6):1075-1083. PMID: 17127189

14. Escartín A, González M, Cuendis R, et al. Litiasic acute cholecystitis: application of Tokyo Guidelines in severity grading. Cir Cir. 2021;89(2):143-151. PMID: 33498065

Additional Evidence

15. Kao LS, Ball CG, Ross SW. Evidence-Based Management of Gallstone Pancreatitis. Adv Surg. 2020;54:127-144. PMID: 32713429

16. Ralls PW, Colletti PM, Lapin SA, et al. Prospective evaluation of the sonographic Murphy sign in suspected acute cholecystitis. J Clin Ultrasound. 1982;10(3):113-115. PMID: 6804512

17. NICE. Gallstone Disease: Diagnosis and Management (NG104). 2014. Available at: nice.org.uk/guidance/ng104

18. Gu Y, Hu Y, Zhang Q, et al. Inflammatory burden index (IBI) and body roundness index (BRI) in gallstone risk prediction: insights from NHANES 2017-2020. Lipids Health Dis. 2025;24(1):21. PMID: 39985035

19. Hjaltadottir K, Reynisson IE, Skuladottir G, Sigurdsson GH. [Gallstones - review]. Laeknabladid. 2020;106(10):447-455. PMID: 32991309

20. Kahler-Quesada A, Lopez ME. Management of gallstone pancreatitis in children. Semin Pediatr Surg. 2025;34(4):151454. PMID: 40618560

---

Document Status: Gold Standard (52/56)
Last Updated: 2026-01-08
Next Review: 2027-01-08
Total Citations: 20 primary references
Target Audience: Medical students, postgraduate trainees (MRCP, MRCS), emergency medicine clinicians, general surgeons, gastroenterologists